12th November 2020
- Funding Pressure Could Return Via Year-End GSIB Scores: JPMorgan
- Funding Pressure Unlikely to Re-Emerge From GSIB Scores: Pozsar
- This Covid Surge Is America’s Longest — and It’s Getting Longer
- Moderna Poised to Take Vaccine Spotlight With Data Due
Initial verdict could come in days as national cases ramp up
Effectiveness expected to be similar to Pfizer’s 90% rate
For more information please contact Rubrics Asset Management. email@example.com.